Adalimumab vs Efalizumab

## Adalimumab vs Efalizumab: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Efalizumab**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Efalizumab — N/A.

## Chemical Properties

**Type**: Adalimumab — Antibody; Efalizumab — Antibody.